IL-10-deficient mice demonstrate multiple organ failure and increased mortality during Escherichia coli peritonitis despite an accelerated bacterial clearance

Journal of Immunology

Volumn 166, Issue 10, 2001, Pages 6323-6331

  Sewnath, Miguel E ^a   Olszyna, Dariusz P ^a   Birjmohun, Rakesh ^a   Ten Kate, Fiebo J W ^a   Gouma, Dirk J ^a   Van Der Poll, Tom ^a,b  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BACTERIAL OVERGROWTH; BACTERICIDAL ACTIVITY; BLOOD; CLINICAL CHEMISTRY; CONTROLLED STUDY; CYTOKINE RELEASE; DOSE RESPONSE; ESCHERICHIA COLI; HISTOPATHOLOGY; HOST RESISTANCE; IMMUNE RESPONSE; LUNG; MALE; MOUSE; MULTIPLE ORGAN FAILURE; NEUTROPHIL; NONHUMAN; PERITONEAL FLUID; PERITONITIS; PRIORITY JOURNAL; SURVIVAL; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 0035873382     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.166.10.6323     Document Type: Article

References (51)

1. Bosscha, K., K. Reijnders, P. F. Hulstaert, A. Algra, and C. van der Werken. 1997. Prognostic scoring systems to predict outcome in peritonitis and intraabdominal sepsis. Br. J. Surg. 84:1532.
2. Ohmann, C., Q. Yang, T. Hau, and H. Wacha. 1997. Prognostic modelling in peritonitis. Peritonitis Study Group of the Surgical Infection Society Europe. Eur. J. Surg. 163:53.
3. Christou, N. V., P. S. Barie, E. P. Dellinger, J. P. Waymack, and H. H. Stone. 1993. Surgical Infection Society intra-abdominal infection study: prospective evaluation of management techniques and outcome. Arch. Surg. 128:193.
4. Wheeler, A. P., and G. R. Bernard. 1999. Treating patients with severe sepsis. N. Engl. J. Med. 340:207.
5. Holzheimer, R. G., K. H. Muhrer, N. L'Allemand, T. Schmidt, and K. Henneking. 1991. Intraabdominal infections: classification, mortality, scoring and pathophysiology. Infection 19:447.
6. Hau, T. 1990. Bacteria, toxins, and the peritoneum. World J. Surg. 14:167.
7. Lorber, B., and R. M. Swenson. 1975. The bacteriology of intra-abdominal infections. Surg. Clin. North Am. 55:1349.
8. Cohen, M. L. 1992. Epidemiology of drug resistance: implications for a post-antimicrobial era. Science 257:1050.
9. Gold, H. S., and R. C. Moellering, Jr. 1996. Antimicrobial-drug resistance. N. Engl. J. Med. 335:1445.
10. Jarlier, V., T. Fosse, and A. Philippon. 1996. Antibiotic susceptibility in aerobic Gram-negative bacilli isolated in intensive care units in 39 French teaching hospitals (ICU study). Intensive Care Med. 22:1057.
11. Burwen, D. R., S. N. Banerjee, and R. P. Gaynes. 1994. Ceftazidime resistance among selected nosocomial Gram-negative bacilli in the United States: National Nosocomial Infections surveillance system. J. Infect. Dis. 170:1622.
12. van der Poll, T., and S. J. van Deventer. 2000. Cytokines and anticytokines in the pathogenesis of sepsis. Infect. Dis. Clin. North Am. 13:413.
13. Tracey, K. J., Y. Fong, D. G. Hesse, K. R. Manogue, A. T. Lee, G. C. Kuo, S. F. Lowry, and A. Cerami. 1987. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature 330:662.
14. Hinshaw, L. B., P. Tekamp-Olson, A. C. Chang, P. A. Lee, F. B. Taylor, Jr., C. K. Murray, G. T. Peer, T. E. Emerson, Jr., R. B. Passey, and G. C. Kuo. 1990. Survival of primates in LD100 septic shock following therapy with antibody to tumor necrosis factor (TNF α). Circ. Shock 30:279.
15. Fischer, E., M. A. Marano, K. J. Van Zee, C. S. Rock, A. S. Hawes, W. A. Thompson, L. DeForge, J. S. Kenney, D. G. Remick, and D. C. Bloedow. 1992. Interleukin-1 receptor blockade improves survival and hemodynamic per-formance in Escherichia coli septic shock, but fails to alter host responses to sublethal endotoxemia. J. Clin. Invest. 89:1551.
16. Echlenacher, B., W. Falk, D. N. Mannel, and P. H. Krammer. 1990. Requirement of endogenous tumor necrosis factor/cachectin for recovery from experimental peritonitis. J. Immunol. 145:3762.
17. Echtenacher, B., D. N. Mannel, and L. Hultner. 1996. Critical protective role of mast cells in a model of acute septic peritonitis. Nature 381:75.
18. Laichalk, L. L., S. L. Kunkel, R. M. Strieter, J. M. Danforth, M. B. Bailie, and T. J. Standiford. 1996. Tumor necrosis factor mediates lung antibacterial host defense in murine Klebsiella pneumonia. Infect. Immun. 64:5211.
19. van der Poll, T., C. V. Keogh, W. A. Buurman, and S. F. Lowry. 1997. Passive immunization against tumor necrosis factor-α impairs host defense during pneumococcal pneumonia in mice. Am. J. Respir. Crit. Care Med. 155:603.
20. Moore, K. W., A. O'Garra, M. R. de Waal, P. Vieira, and T. R. Mosmann. 1993. Interleukin-10. Annu. Rev. Immunol. 11:165.
21. Opal, S. M., J. C. Wherry, and P. Grint. 1998. Interleukin-10: potential benefits and possible risks in clinical infectious diseases. Clin. Infect. Dis. 27:1497.
22. de Waal Malefyt, R., J. Abrams, B. Bennett, C. G. Figdor, and J. E. de Vries. 1991. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J. Exp. Med. 174:1209.
23. Gerard, C., C. Bruyns, A. Marchant, D. Abramowicz, P. Vandenabeele, A. Delvaux, W. Fiers, M. Goldman, and T. Velu. 1993. Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia. J. Exp. Med. 177:547.
24. Howard, M., T. Muchamuel, S. Andrade, and S. Menon. 1993. Interleukin 10 protects mice from lethal endotoxemia. J. Exp. Med. 177:1205.
25. Pajkrt, D., L. Camoglio, M. C. Tiel-van Buul, K. de Bruin, D. L. Cutler, M. B. Affrime, G. Rikken, T. van der Poll, J. W. ten Cate, and S. J. van Deventer. 1997. Attenuation of proinflammalory response by recombinant human IL-10 in human endotoxemia: effect of timing of recombinant human IL-10 administration. J. Immunol. 158:3971.
26. van der Poll, T., P. M. Jansen, W. J. Montegut, C. C. Braxton, S. E. Calvano, S. A. Stackpole, S. R. Smith, S. W. Swanson, C. E. Hack, S. F. Lowry, and L. L. Moldawer. 1997. Effects of IL-10 on systemic inflammatory responses during sublethal primate endotoxemia. J. Immunol. 158:1971.
27. Marchant, A., J. Deviere, B. Byl, D. De Groote, J. L. Vincent, and M. Goldman. 1994. Interleukin-10 production during septicaemia. Lancet 343:707.
28. van der Poll, T., R. de Waal Malefyt, S. M. Coyle, and S. F. Lowry. 1997. Antiinflammatory cytokine responses during clinical sepsis and experimental endotoxemia: sequential measurements of plasma soluble interleukin (IL)-1 receptor type II, IL-10, and IL-13. J. Infect. Dis. 175:118.
29. Marchant, A., C. Bruyns, P. Vandenabeele, M. Ducarme, C. Gerard, A. Delvaux, D. De Groote, D. Abramowicz, T. Velu, and M. Goldman. 1994. Interleukin-10 controls interferon-γ and tumor necrosis factor production during experimental endotoxemia. Eur. J. Immunol. 24:1167.
30. Standiford, T. J., R. M. Strieter, N. W. Lukacs, and S. L. Kunkel. 1995. Neutralization of IL-10 increases lethality in endotoxemia: cooperative effects of macrophage inflammatory protein-2 and tumor necrosis factor. J. Immunol. 155: 2222.
31. Berg, D. J., R. Kuhn, K. Rajewsky, W. Muller, S. Menon, N. Davidson, Grunig, G., and D. Rennick. 1995. Interleukin-10 is a central regulator of the response to LPS in murine models of endotoxic shock and the Shwartzman reaction but not endotoxin tolerance. J. Clin. Invest. 96:2339.
32. Greenberger, M. J., R. M. Strieter, S. L. Kunkel, J. M. Danforth, R. E. Goodman, and T. J. Standiford. 1995. Neutralization of IL-10 increases survival in a murine model of Klebsiella pneumonia. J. Immunol. 155:722.
33. van der Poll, T., A. Marchant, C. V. Keogh, M. Goldman, and S. F. Lowry. 1996. Interleukin-10 impairs host defense in murine pneumococcal pneumonia. J. Infect. Dis. 174:994.
34. van der Poll, T., A. Marchant, W. A. Buurman, L. Berman, C. V. Keogh, D. D. Lazarus, L. Nguyen, M. Goldman, L. L. Moldawer, and S. F. Lowry. 1995. Endogenous IL-10 protects mice from death during septic peritonitis. J. Immunol. 155:5397.
35. Kato, T., A. Murata, H. Ishida, H. Toda, N. Tanaka, H. Hayashida, M. Monden, and N. Matsuura. 1995. Interleukin 10 reduces mortality from severe peritonitis in mice. Antimicrob. Agents Chemother. 39:1336.
36. Luster, A. D. 1998. Chemokines-chemotactic cytokines that mediate inflammation. N. Engl. J. Med. 338:436.
37. McClean, K. L., G. J. Sheehan, and G. K. Harding. 1994. Intraabdominal infection: a review. Clin. Infect. Dis. 19:100.
38. Tracey, K. J., S. F. Lowry, T. J. Fahey III, J. D. Albert, Y. Fong, D. Hesse, B. Beutler, K. R. Manogue, S. Calvano, and H. Wei. 1987. Cachectin/tumor necrosis factor induces lethal shock and stress hormone responses in the dog. Surg. Gynecol. Obstet. 164:415.
39. Tracey, K. J., B. Beutler, S. F. Lowry, J. Merryweather, S. Wolpe, I. W. Milsark, R. J. Hariri, T. J. Fahey III, A. Zentella, and J. D. Albert. 1986. Shock and tissue injury induced by recombinant human cachectin. Science 234:470.
40. Fink, M. P., and S. O. Heard. 1990. Laboratory models of sepsis and septic shock. J. Surf. Res. 49:186.
41. Bagby, G. J., K. J. Plessala, L. A. Wilson, J. J. Thompson, and S. Nelson. 1991. Divergent efficacy of antibody to tumor necrosis factor-α in intravascular and peritonitis models of sepsis. J. Infect. Dis. 163:83.
42. Zanelti, G., D. Heumann, J. Gerain, J. Kohler, P. Abbet, C. Barras, Lucas, R., M. P. Glauser, and J. D. Baumgartner. 1992. Cytokinc production after intravenous or peritoneal Gram-negative bacterial challenge in mice: comparative protective efficacy of antibodies to tumor necrosis factor-α and to lipopolysaccharide. J. Immunol. 148:1890.
43. Eskandari, M. K., G. Bolgos, C. Miller, D. T. Nguyen, L. E. DeForge, and D. G. Remick. 1992. Anti-tumor necrosis factor antibody therapy fails to prevent lethality after cecal ligation and puncture or endotoxemia. J. Immunol. 148:2724.
44. Matsukawa, A., C. M. Hogaboam, N. W. Lukacs, P. M. Lincoln, H. L. Evanoff, R. M. Stricter, and S. L. Kunkel. 2000. Expression and contribution of endogenous IL-13 in an experimental model of sepsis. J. Immunol. 164:2738.
45. Walley, K. R., N. W. Lukacs, T. J. Standiford, R. M. Strieter, and S. L. Kunkel 1997. Elevated levels of macrophage inflammatory protein 2 in severe murine pritonitis increase neutrophil recruitment and mortality. Infect. Immun. 65:1847.
46. Tsai, W. C., R. M. Strieter, J. M. Wilkowski, K. A. Bucknell, M. D. Burdick, S. A. Lira, and T. J. Standiford. 1998. Lung-specific transgenic expression of KC enhances resistance to Klebsiella pneumoniae in mice. J. Immunol. 161:2435.
47. Dalrymple, S. A., R. Slattery, D. M. Aud, M. Krishna, L. A. Lucian, and R. Murray. 1996. Interleukin-6 is required for a protective immune response to systemic Escherichia coli infection. Infect. Immun. 64:3231.
48. Kawachi, S., S. Jennings, J. Panes, A. Cockrell, F. S. Laroux, L. Gray, M. Perry, H. van der Heyde, E. Balish, D. N. Granger, et al. 2000. Cytokine and endothelial cell adhesion molecule expression in interleukin-10-deficient mice. Am. J. Physiol. Gastrointest. Liver Physiol. 278:C734.
49. Henke, P. K., L. A. DeBrunye, R. M. Strieter, J. S. Bromberg, M. Prince, A. M. Kadell, M. Sarkar, F. Londy, and T. W. Wakefield. 2000. Viral IL-10 gene transfer decreases inflammation and cell adhesion molecule expression in a rat model of venous thrombosis. J. Immunol. 164:2131.
50. Keel, M., U. Ungethum, U. Steckholzer, E. Niederer, T. Hartung, O. Trentz, and W. Ertel. 1997. Interleukin-10 counterregulates proinflammatory cytokine-induced inhibition of neutrophil apoptosis during severe sepsis. Blood 90:3356.
51. Hess, P. J., J. M. Seeger, T. S. Huber, M. B. Welbom, T. D. Martin, T. R. Harward, S. Duschek, P. D. Edwards, C. C. Solorzano, E. M. Copeland, and L. L. Moldawer. 1997. Exogenously administered interleukin-10 decreases pulmonary neutrophil infiltration in a tumor necrosis factor-dependent murine model of acute visceral ischemia. J. Vasc. Surg. 26:113.